Poseida Lands $23,033,232 New Funding

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=5129a137-ed72-46d9-a194-c94f60d33d99
Date
12/28/2015
Company Name
Poseida
Mailing Address
4250 Executive Square La Jolla, CA 92037 USA
Company Description
Poseida Therapeutics is a spin out of Transposagen Biopharmaceuticals that utilizes best-in-class, proprietary genome editing technologies to develop targeted, life-saving therapeutics in areas of high unmet medical need.
Website
http://www.poseida.com
Transaction Type
Venture Equity
Transaction Amount
$23,033,232
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.
M&A Terms
Venture Investor
Undisclosed